Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
Recruiting now
Conditions studied: Chronic Hepatitis B, Nonalcoholic Fatty Liver Disease
In brief
The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).
Key facts
- Study ID
- NCT02863757
- Run by
- Humanity and Health Research Centre
- People needed
- 1500
- Starts
- 2016-08-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-07-29
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Liver biopsy proved CHB and/or NAFLD at baseline;
- Chinese
- Follow-up duration>12 months
You may not qualify if…
- Other liver diseases;
- Secondary causes of hepatic steatosis;
- Alcohol abuse;
- Liver cirrhosis, cirrhosis related complications or HCC at baseline;
- Malignancy;
- History of liver transplantation
Where it is running
- Humanity and Health GI and Liver Centre — Hong Kong, Hong Kong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.